SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-001023
Filing Date
2017-02-06
Accepted
2017-02-06 16:16:26
Documents
56
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20161231.htm 10-Q 1196862
2 EX-31.1 arwr-ex311_8.htm EX-31.1 10863
3 EX-31.2 arwr-ex312_9.htm EX-31.2 11277
4 EX-32.1 arwr-ex321_10.htm EX-32.1 6704
5 EX-32.2 arwr-ex322_6.htm EX-32.2 6920
  Complete submission text file 0001564590-17-001023.txt   4435858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20161231.xml EX-101.INS 686718
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20161231.xsd EX-101.SCH 39651
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20161231_cal.xml EX-101.CAL 45288
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20161231_def.xml EX-101.DEF 147847
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20161231_lab.xml EX-101.LAB 365327
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20161231_pre.xml EX-101.PRE 285021
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-21898 | Film No.: 17575785
SIC: 2834 Pharmaceutical Preparations